Ivan J. Perry

Ivan J. Perry

Auto-generated profile, based on publicly available information

Ivan J. Perry

School of Public Health, University College Cork, Cork, Ireland

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in The Lancet
Verified
Journal Article
Closed access
JSJames Shepherd
James Shepherd
GBGerard J Blauw
Gerard J Blauw
MMMichael B Murphy
Michael B Murphy
EBEdward Lem Bollen
Edward Lem Bollen
BBBrendan M Buckley
Brendan M Buckley
RWRudi Gj Westendorp
Rudi Gj Westendorp

1 November 1995 in The Lancet
Verified
Journal Article
Closed access
IPI.J. Perry
I.J. Perry
RMRichard Morris
Richard Morris
SES.B. Ebrahim
S.B. Ebrahim
ASA.G. Shaper
A.G. Shaper
HRH. Refsum
H. Refsum
PUP.M. Ueland
P.M. Ueland

4 March 1995 in BMJ
Verified
Journal Article
Closed access
IPIvan J Perry
Ivan J Perry
SWS Goya Wannamethee
S Goya Wannamethee
MWMary K Walker
Mary K Walker
ATA G Thomson
A G Thomson
PWPeter H Whincup
Peter H Whincup
ASA Gerald Shaper
A Gerald Shaper
Objective : To determine the risk factors for non-insulin dependent diabetes in a cohort representative of middle aged British men. Design : Prospective study. Subjects and setting : 7735 men aged 40-59, drawn from one group practice in each of 24 towns in Britain. Known and probable cases of diabetes at screening (n=158) were excluded. Main outcome measures : Non-insulin dependent diabetes (doctor diagnosed) over a mean follow up period of 12.8 years. Results : There were 194 new cases of non-insulin dependent diabetes. Body mass index was the dominant risk factor for diabetes, with an age adjusted relative risk (upper fifth to lower fifth) of 11.6; 95% confidence interval 5.4 to 16.8. Men engaged in moderate levels of physical activity had a substantially reduced risk of diabetes, relative to the physically inactive men, after adjustment for age and body mass index (0.4; 0.2 to 0.7), an association which persisted in full multivariate analysis. A non-linear relation between alcohol intake and diabetes was observed, with the lowest risk among moderate drinkers (16-42 units/week) relative to the baseline group of occasional drinkers (0.6; 0.4 to 1.0). Additional significant predictors of diabetes in multivariate analysis included serum triglyceride concentration, high density lipoprotein cholesterol concentration (inverse association), heart rate, uric acid concentration, and prevalent coronary heart disease. Conclusion : These findings emphasise the interrelations between risk factors for non-insulin dependent diabetes and coronary heart disease and the potential value of an integrated approach to the prevention of these conditions based on the prevention of obesity and the promotion of physical activity. Key messages: Key messages This study shows a strong, graded association between body mass index and risk of diabetes in middle aged men, with no evidence of a threshold effect The risk of diabetes is reduced by more than 50% among men who take moderately vigorous exercise Cardiovascular disease risk factors that are linked with insulin resistance, such as hypertriglyceridaemia and hyperuricaemia, predict non-insulin dependent diabetes These findings support an integrated approach to the prevention of non-insulin dependent diabetes and cardiovascular disease based on the prevention of obesity and the promotion of physical activity

11 February 2009 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
MCM. M. Collins
M. M. Collins
PCP. Corcoran
P. Corcoran
IPI. J. Perry
I. J. Perry

27 September 2014 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
AGAmadou Gaye
Amadou Gaye
YMYannick Marcon
Yannick Marcon
JIJulia Isaeva
Julia Isaeva
PLPhilippe LaFlamme
Philippe LaFlamme
ATAndrew Turner
Andrew Turner
PBPaul Burton
Paul Burton
Background: Research in modern biomedicine and social science requires sample sizes so large that they can often only be achieved through a pooled co-analysis of data from several studies. But the pooling of information from individuals in a central database that may be queried by researchers raises important ethico-legal questions and can be controversial. In the UK this has been highlighted by recent debate and controversy relating to the UK’s proposed ‘care.data’ initiative, and these issues reflect important societal and professional concerns about privacy, confidentiality and intellectual property. DataSHIELD provides a novel technological solution that can circumvent some of the most basic challenges in facilitating the access of researchers and other healthcare professionals to individual-level data. Methods: Commands are sent from a central analysis computer (AC) to several data computers (DCs) storing the data to be co-analysed. The data sets are analysed simultaneously but in parallel. The separate parallelized analyses are linked by non-disclosive summary statistics and commands transmitted back and forth between the DCs and the AC. This paper describes the technical implementation of DataSHIELD using a modified R statistical environment linked to an Opal database deployed behind the computer firewall of each DC. Analysis is controlled through a standard R environment at the AC. Results: Based on this Opal/R implementation, DataSHIELD is currently used by the Healthy Obese Project and the Environmental Core Project (BioSHaRE-EU) for the federated analysis of 10 data sets across eight European countries, and this illustrates the opportunities and challenges presented by the DataSHIELD approach. Conclusions: DataSHIELD facilitates important research in settings where: (i) a co-analysis of individual-level data from several studies is scientifically necessary but governance restrictions prohibit the release or sharing of some of the required data, and/or render data access unacceptably slow; (ii) a research group (e.g. in a developing nation) is particularly vulnerable to loss of intellectual property—the researchers want to fully share the information held in their data with national and international collaborators, but do not wish to hand over the physical data themselves; and (iii) a data set is to be included in an individual-level co-analysis but the physical size of the data precludes direct transfer to a new site for analysis.

1 May 1998 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
IPIvan J Perry
Ivan J Perry
SWS Goya Wannamethee
S Goya Wannamethee
ASA Gerald Shaper
A Gerald Shaper
OBJECTIVE: Serum γ-glutamyltransferase (GGT) levels are raised inobese individuals, and a particularly strong association with central obesity has been described. We hypothesized that elevated GGT levels are a marker for visceral fat, and specifically for hepatic steatosis (fatty liver), and that hepatic steatosis leads to hepatic insulin resistance. To test this hypothesis, we examined the association between GGT levels and risk of NIDDM. RESEARCH DESIGN AND METHODS: We carried out a prospective cohort study of incident cases of doctor-diagnosed NIDDM in a group of 7,458 nondiabetic men (aged 40–59 years) followed for a mean of 12.8 years (range 11.5–13.0). The men were randomly selected from general practice lists in 24 British towns. Cases of NIDDM were ascertained by repeated postal questionnaires to the men and by regular systematic review of primary care records. RESULTS: A total of 194 men developed NIDDM during follow-up. Mean serum GGT at baseline (geometric mean [95% Cl]) was significantly higher in the NIDDM patients than in the rest of the cohort (20.9 [19.3–22.6] vs. 15.3 U/l [15.0–15.6], P < 0.0001). There was a smooth, graded increase in the age-adjusted risk of NIDDM with increasing GGT levels, with a relative risk in the top fifth of the distribution of 6.8 (3.5–12.9) relative to the bottom fifth (trend P < 0.0001). This association was independent of serum glucose and BMI and of other predictors of NIDDM with which GGT is associated, including alcohol intake and physical activity level (adjusted upper to lower fifth relative risk: 4.8 [2.0–11.8], trend P < 0.0001]). CONCLUSIONS: These findings suggest that a raised serum GGT levelis an independent risk factor for NIDDM. Serum GGT level may be a simple andreliable marker of visceral and hepatic fat and, by inference, of hepatic insulin resistance.